International Conference on
Alzheimers and Dementia Diseases Conference
Theme: “Innovations and Advances in Alzheimer’s and Dementia Research”
July 21-22, 2025 | Vancouver, Canada
About Alzheimers Dementia Diseases
We invite you to attend the International Conference on Alzheimers and Dementia Diseases, taking place on July 21–22, 2025, in Vancouver, Canada. Under the theme “Innovations and Advances in Alzheimers and Dementia Research,” this international Alzheimers and Dementia Diseases Conference event is designed for researchers, educators, healthcare professionals, and specialists in neurology, geriatrics, and cognitive sciences. Engage with pressing topics, present your findings, and network with leading experts in the fields of Alzheimers, dementia, cognitive health, and therapeutic innovations. This is a unique opportunity to engage in meaningful discussions and gain valuable insights into the latest developments in Alzheimers and dementia research.
We eagerly anticipate your involvement in what is sure to be an informative and collaborative gathering.
Scientific Sessions
Alzheimer’s disease pathogenesis involves abnormal protein accumulation, leading to neurodegeneration and cognitive decline.
Related Conferences: Neurology and Neurosurgery conference 2025 | Psychology Conference | Brain Disorders Conference | Alzheimers and Dementia Diseases Conference | Stroke and Cerebrovascular Diseases Conference | Psychiatry and Mental disorder Conference | Neuroscience Conference
Genetic factors, including APOE variants, significantly influence Alzheimer’s disease susceptibility and progression.
Related Conferences: Neurology and Neurosurgery conference 2025 | Psychology Conference | Brain Disorders Conference | Alzheimers and Dementia Diseases Conference | Stroke and Cerebrovascular Diseases Conference | Psychiatry and Mental disorder Conference | Neuroscience Conference
Risk factors include age, genetics, cardiovascular health, and lifestyle habits impacting dementia’s development.
Related Conferences: Neurology and Neurosurgery conference 2025 | Psychology Conference | Brain Disorders Conference | Alzheimers and Dementia Diseases Conference | Stroke and Cerebrovascular Diseases Conference | Psychiatry and Mental disorder Conference | Neuroscience Conference
Early diagnosis of Alzheimer’s improves treatment outcomes, focusing on biomarkers and cognitive assessment.
Related Conferences: Neurology and Neurosurgery conference 2025 | Psychology Conference | Brain Disorders Conference | Alzheimers and Dementia Diseases Conference | Stroke and Cerebrovascular Diseases Conference | Psychiatry and Mental disorder Conference | Neuroscience Conference
Neuroinflammation accelerates dementia progression, with immune response playing a critical role in Alzheimer’s pathology.
Related Conferences: Neurology and Neurosurgery conference 2025 | Psychology Conference | Brain Disorders Conference | Alzheimers and Dementia Diseases Conference | Stroke and Cerebrovascular Diseases Conference | Psychiatry and Mental disorder Conference | Neuroscience Conference
Sleep disturbances are linked to Alzheimer’s, affecting brain detoxification and accelerating cognitive decline.
Related Conferences: Neurology and Neurosurgery conference 2025 | Psychology Conference | Brain Disorders Conference | Alzheimers and Dementia Diseases Conference | Stroke and Cerebrovascular Diseases Conference | Psychiatry and Mental disorder Conference | Neuroscience Conference
Dementia care requires comprehensive management, addressing cognitive, behavioral, and emotional needs of patients.
Related Conferences: Neurology and Neurosurgery conference 2025 | Psychology Conference | Brain Disorders Conference | Alzheimers and Dementia Diseases Conference | Stroke and Cerebrovascular Diseases Conference | Psychiatry and Mental disorder Conference | Neuroscience Conference
Therapies target amyloid plaques, tau proteins, and neuroinflammation in Alzheimer’s disease treatments.
Related Conferences: Neurology and Neurosurgery conference 2025 | Psychology Conference | Brain Disorders Conference | Alzheimers and Dementia Diseases Conference | Stroke and Cerebrovascular Diseases Conference | Psychiatry and Mental disorder Conference | Neuroscience Conference
Healthy lifestyle choices, including exercise and diet, reduce dementia risk and improve cognitive health.
Related Conferences: Neurology and Neurosurgery conference 2025 | Psychology Conference | Brain Disorders Conference | Alzheimers and Dementia Diseases Conference | Stroke and Cerebrovascular Diseases Conference | Psychiatry and Mental disorder Conference | Neuroscience Conference
Current therapies for Alzheimer’s aim to slow disease progression and improve patient quality of life.
Related Conferences: Neurology and Neurosurgery conference 2025 | Psychology Conference | Brain Disorders Conference | Alzheimers and Dementia Diseases Conference | Stroke and Cerebrovascular Diseases Conference | Psychiatry and Mental disorder Conference | Neuroscience Conference
Venue Attractions
- Connecting Rooms
- Hot breakfast
- Free WiFi
- Concierge
- Non-smoking rooms
- Digital Key
- On-site restaurant
- Fitness center
- Express Mail
- Pet-friendly rooms
- Room service
- Meeting rooms
Get in Touch
Address
16192 Coastal Highway Lewes, Delaware, USA 19958
Phone number
+1 630 768 1199
E-mail address
support@stripeconferences.com
Media Partners
CONTACT US
Frequently Asked Questions (FAQS)
Researchers, neurologists, healthcare professionals, and specialists in dementia management should attend this International Alzheimers Conference.
Age, genetics, cardiovascular health, and lifestyle are the primary risk factors discussed at the Dementia Diseases Conference 2025.
Therapeutic targets include amyloid plaques, tau proteins, and neuroinflammation, explored at the Alzheimers Diseases Conference 2025.
Neuroimaging techniques, such as MRI and PET scans, are crucial for early diagnosis and monitoring of Alzheimer’s disease.
Neuroinflammation contributes to disease progression, with treatment strategies discussed at the International Dementia Conference.